Supplementing exposure to hypoxia with a copper depleted diet does not exacerbate right ventricular remodeling in mice

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Poels, Ella M ^a   Bitsch, Nicole ^a   Slenter, Jos M ^a   Kooi, M Eline ^a   De Theije, Chiel C ^b   De Windt, Leon J ^a   Van Empel, Vanessa P M ^c   Da Costa Martins, Paula A ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; COPPER; TRANSCRIPTION FACTOR NFAT; BIOLOGICAL MARKER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CONTROLLED STUDY; COPPER DEFICIENCY; DIET; DISEASE EXACERBATION; ECHOCARDIOGRAPHY; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE HYPERTROPHY; HEART WEIGHT; HYPOXIA; LONG TERM EXPOSURE; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANIMAL; ANOXIA; COMPLICATION; DIET SUPPLEMENTATION; DISEASE MODEL; HEART FAILURE; HEART STROKE VOLUME; HEART VENTRICLE; HEART VENTRICLE REMODELING; HYPERTROPHY, RIGHT VENTRICULAR; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGICAL STRESS; PULMONARY HYPERTENSION;

ANIMALS; ANOXIA; BIOLOGICAL MARKERS; COPPER; DIET; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; HEART FAILURE; HEART VENTRICLES; HYPERTENSION, PULMONARY; HYPERTROPHY, RIGHT VENTRICULAR; MALE; MICE; STRESS, PHYSIOLOGICAL; STROKE VOLUME; VENTRICULAR REMODELING;

EID: 84899688428     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092983     Document Type: Article

References (47)

1. Chin KM, Kim NH, Rubin LJ (2005) The right ventricle in pulmonary hypertension. Coron Artery Dis 16: 13-18.
2. Chin KM, Rubin LJ (2008) Pulmonary arterial hypertension. J Am Coll Cardiol 51: 1527-1538.
3. Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, et al. (2009) Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 30: 2493-2537.
4. Howard LS (2011) Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease. Eur Respir Rev 20: 236-242.
5. Rubin LJ (1997) Primary pulmonary hypertension. N Engl J Med 336: 111-117.
6. Brown L, Miller J, Dagger A, Sernia C (1998) Cardiac and vascular responses after monocrotaline-induced hypertrophy in rats. Journal of cardiovascular pharmacology 31: 108-115.
7. Pelouch V, Kolar F, Ost'adal B, Milerova M, Cihak R, et al. (1997) Regression of chronic hypoxia-induced pulmonary hypertension, right ventricular hypertrophy, and fibrosis: effect of enalapril. Cardiovascular drugs and therapy/ sponsored by the International Society of Cardiovascular Pharmacotherapy 11: 177-185.
8. Stenmark KR, Fagan KA, Frid MG (2006) Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circulation research 99: 675-691.
9. Stenmark KR, Meyrick B, Galie N, Mooi WJ, McMurtry IF (2009) Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure. American journal of physiology Lung cellular and molecular physiology 297: L1013-1032.
10. Bauer EM, Zheng H, Comhair S, Erzurum S, Billiar TR, et al. (2011) Complement C3 deficiency attenuates chronic hypoxia-induced pulmonary hypertension in mice. PloS one 6: e28578.
11. Brusselmans K, Compernolle V, Tjwa M, Wiesener MS, Maxwell PH, et al. (2003) Heterozygous deficiency of hypoxia-inducible factor-2alpha protects mice against pulmonary hypertension and right ventricular dysfunction during prolonged hypoxia. The Journal of clinical investigation 111: 1519-1527.
12. Calmettes G, Deschodt-Arsac V, Gouspillou G, Miraux S, Muller B, et al. (2010) Improved energy supply regulation in chronic hypoxic mouse counteracts hypoxia-induced altered cardiac energetics. PloS one 5: e9306.
13. Caruso P, Dempsie Y, Stevens HC, McDonald RA, Long L, et al. (2012) A role for miR-145 in pulmonary arterial hypertension: evidence from mouse models and patient samples. Circulation research 111: 290-300.
14. Ciuclan L, Bonneau O, Hussey M, Duggan N, Holmes AM, et al. (2011) A novel murine model of severe pulmonary arterial hypertension. American journal of respiratory and critical care medicine 184: 1171-1182.
15. Paddenberg R, Stieger P, von Lilien AL, Faulhammer P, Goldenberg A, et al. (2007) Rapamycin attenuates hypoxia-induced pulmonary vascular remodeling and right ventricular hypertrophy in mice. Respiratory research 8: 15
16. Scherrer-Crosbie M, Steudel W, Hunziker PR, Foster GP, Garrido L, et al. (1998) Determination of right ventricular structure and function in normoxic and hypoxic mice: a transesophageal echocardiographic study. Circulation 98: 1015-1021.
17. Steudel W, Scherrer-Crosbie M, Bloch KD, Weimann J, Huang PL, et al. (1998) Sustained pulmonary hypertension and right ventricular hypertrophy after chronic hypoxia in mice with congenital deficiency of nitric oxide synthase 3. The Journal of clinical investigation 101: 2468-2477.
18. van Suylen RJ, Aartsen WM, Smits JF, Daemen MJ (2001) Dissociation of pulmonary vascular remodeling and right ventricular pressure in tissue angiotensin-converting enzyme-deficient mice under conditions of chronic alveolar hypoxia. American journal of respiratory and critical care medicine 163: 1241-1245.
19. Vanderpool RR, El-Bizri N, Rabinovitch M, Chesler NC (2013) Patchy deletion of Bmpr1a potentiates proximal pulmonary artery remodeling in mice exposed to chronic hypoxia. Biomechanics and modeling in mechanobiology 12: 33-42.
20. Yoshikawa N, Shimizu N, Maruyama T, Sano M, Matsuhashi T, et al. (2012) Cardiomyocyte-specific overexpression of HEXIM1 prevents right ventricular hypertrophy in hypoxia-induced pulmonary hypertension in mice. PloS one 7: e52522.
21. Yu AY, Shimoda LA, Iyer NV, Huso DL, Sun X, et al. (1999) Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1alpha. The Journal of clinical investigation 103: 691-696.
22. Zhang Y, Talwar A, Tsang D, Bruchfeld A, Sadoughi A, et al. (2012) Macrophage migration inhibitory factor mediates hypoxia-induced pulmonary hypertension. Molecular medicine 18: 215-223.
23. Brown RD, Ambler SK, Li M, Sullivan TM, Henry LN, et al. (2013) MAP kinase kinase kinase-2 (MEKK2) regulates hypertrophic remodeling of the right ventricle in hypoxia-induced pulmonary hypertension. American journal of physiology Heart and circulatory physiology 304: H269-281.
24. Cruz JA, Bauer EM, Rodriguez AI, Gangopadhyay A, Zeineh NS, et al. (2012) Chronic hypoxia induces right heart failure in caveolin-12/2 mice. American journal of physiology Heart and circulatory physiology 302: H2518-2527.
25. Sakao S, Taraseviciene-Stewart L, Lee JD, Wood K, Cool CD, et al. (2005) Initial apoptosis is followed by increased proliferation of apoptosis-resistant endothelial cells. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 19: 1178-1180.
26. Bogaard HJ, Natarajan R, Henderson SC, Long CS, Kraskauskas D, et al. (2009) Chronic pulmonary artery pressure elevation is insufficient to explain right heart failure. Circulation 120: 1951-1960.
27. Okada K, Tanaka Y, Bernstein M, Zhang W, Patterson GA, et al. (1997) Pulmonary hemodynamics modify the rat pulmonary artery response to injury. A neointimal model of pulmonary hypertension. The American journal of pathology 151: 1019-1025.
28. Jiang Y, Reynolds C, Xiao C, Feng W, Zhou Z, et al. (2007) Dietary copper supplementation reverses hypertrophic cardiomyopathy induced by chronic pressure overload in mice. The Journal of experimental medicine 204: 657-666.
29. Clark DR, Smith P (1978) Capillary density and muscle fibre size in the hearts of rats subjected to stimulated high altitude. Cardiovascular research 12: 578-584.
30. Shiojima I, Sato K, Izumiya Y, Schiekofer S, Ito M, et al. (2005) Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. The Journal of clinical investigation 115: 2108-2118.
31. Izumiya Y, Shiojima I, Sato K, Sawyer DB, Colucci WS, et al. (2006) Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload. Hypertension 47: 887-893.
32. Bogaard HJ, Mizuno S, Guignabert C, Al Hussaini AA, Farkas D, et al. (2012) Copper dependence of angioproliferation in pulmonary arterial hypertension in rats and humans. American journal of respiratory cell and molecular biology 46: 582-591.
33. da Costa Martins PA, Bourajjaj M, Gladka M, Kortland M, van Oort RJ, et al. (2008) Conditional dicer gene deletion in the postnatal myocardium provokes spontaneous cardiac remodeling. Circulation 118: 1567-1576.
34. Dempsey EC, Wick MJ, Karoor V, Barr EJ, Tallman DW, et al. (2009) Neprilysin null mice develop exaggerated pulmonary vascular remodeling in response to chronic hypoxia. The American journal of pathology 174: 782-796.
35. Rabinovitch M, Gamble WJ, Miettinen OS, Reid L (1981) Age and sex influence on pulmonary hypertension of chronic hypoxia and on recovery. The American journal of physiology 240: H62-72.
36. Yet SF, Perrella MA, Layne MD, Hsieh CM, Maemura K, et al. (1999) Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice. The Journal of clinical investigation 103: R23-29.
37. Steiner MK, Syrkina OL, Kolliputi N, Mark EJ, Hales CA, et al. (2009) Interleukin-6 overexpression induces pulmonary hypertension. Circulation research 104: 236-244, 228p following 244.
38. Zhou Y, Bourcy K, Kang YJ (2009) Copper-induced regression of cardiomyocyte hypertrophy is associated with enhanced vascular endothelial growth factor receptor-1 signalling pathway. Cardiovascular research 84: 54-63.
39. Hughes WM, Jr., Rodriguez WE, Rosenberger D, Chen J, Sen U, et al. (2008) Role of copper and homocysteine in pressure overload heart failure. Cardiovascular toxicology 8: 137-144.
40. Wildman RE, Medeiros DM, Hamlin RL, Stills H, Jones DA, et al. (1996) Aspects of cardiomyopathy in copper-deficient pigs. Electrocardiography, echocardiography, and ultrastructural findings. Biological trace element research 55: 55-70.
41. Klevay LM (2000) Cardiovascular disease from copper deficiency-a history. The Journal of nutrition 130: 489S-492S.
42. Klevay LM, Viestenz KE (1981) Abnormal electrocardiograms in rats deficient in copper. The American journal of physiology 240: H185-189.
43. Moraes DL, Colucci WS, Givertz MM (2000) Secondary pulmonary hypertension in chronic heart failure: the role of the endothelium in pathophysiology and management. Circulation 102: 1718-1723.
44. Bartelds B, Borgdorff MA, Smit-van Oosten A, Takens J, Boersma B, et al. (2011) Differential responses of the right ventricle to abnormal loading conditions in mice: pressure vs. volume load. European journal of heart failure 13: 1275-1282.
45. Walker LA, Buttrick PM (2009) The right ventricle: biologic insights and response to disease. Current cardiology reviews 5: 22-28.
46. Ramiro-Diaz JM, Nitta CH, Maston LD, Codianni S, Giermakowska W, et al. (2013) NFAT is required for spontaneous pulmonary hypertension in superoxide dismutase 1 knockout mice. American journal of physiology Lung cellular and molecular physiology 304: L613-625.
47. Wilkins BJ, Dai YS, Bueno OF, Parsons SA, Xu J, et al. (2004) Calcineurin/ NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Circulation research 94: 110-118.